MAP1 Antikörper (AA 337-351)
-
- Target Alle MAP1 Antikörper anzeigen
- MAP1 (Mannosidase Processing 1 (MAP1))
- Bindungsspezifität
- AA 337-351
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MAP1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- Reacts with human 39 kDa MAP-1 protein (residues 337-351)
- Aufreinigung
- Antigen affinity purified
- Immunogen
- residues 337-351 of the human 39 kDa MAP-1 protein.
- Isotyp
- IgG
- Top Product
- Discover our top product MAP1 Primärantikörper
-
-
- Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- WB : 1/500 to 1/1000 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS, Sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Short term storage at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
- Haltbarkeit
- 6 months
-
- Target
- MAP1 (Mannosidase Processing 1 (MAP1))
- Andere Bezeichnung
- MAP1 (MAP1 Produkte)
- Synonyme
- Map-1 antikoerper, Map1 antikoerper, mannosidase processing 1 antikoerper, Blood pressure QTL 196 antikoerper, Map1 antikoerper, Bp196 antikoerper
- Pathways
- Positive Regulation of Endopeptidase Activity
-